AKRO Investors Have Opportunity to Lead Akero Therapeutics, Inc. Securities Fraud Lawsuit

BENSALEM, Pa., May 30, 2024 /PRNewswire/ — Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Akero Therapeutics, Inc. (“Akero” or the “Company”) (NASDAQ: AKRO). Class Period:…